Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy

BACKGROUND: There is legitimate concern that minority drug-resistant mutants may be selected during the initial HIV-1 RNA decay phase following antiretroviral therapy initiation, thus undermining efficacy of treatment. The goal of this study was to characterize viral resistance emergence and address...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguera-Julian, Marc, Casadellà, Maria, Pou, Christian, Rodríguez, Cristina, Pérez-Álvarez, Susana, Puig, Jordi, Clotet, Bonaventura, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867623/
https://www.ncbi.nlm.nih.gov/pubmed/24304606
http://dx.doi.org/10.1186/1743-422X-10-350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867623/
https://www.ncbi.nlm.nih.gov/pubmed/24304606
http://dx.doi.org/10.1186/1743-422X-10-350

Ejemplares similares